Obviously, with the final follow-up we won't get any new reliable outbreaks data, but we should get T-cell & antibody counts, and maybe some anecdotal evidence about further outbreaks from the first 20 subjects (as well as full data for the entire 44 subjects).
Obviously, with the final follow-up we won't get any new...
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$20.05 |
Change
0.500(2.56%) |
Mkt cap ! $386.3M | |||
| Open | High | Low | Value | Volume |
| $19.55 | $20.50 | $19.50 | $392.9K | 19.67K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 123 | $19.92 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $20.10 | 867 | 2 |
View Market Depth
| Last trade - 14.01pm 21/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$20.10 |
Change
0.500 ( 2.71 %) |
||||
| Open | High | Low | Volume | ||
| $19.99 | $20.10 | $19.91 | 302 | ||
| Last updated 12.44pm 21/05/2024 ? | |||||
| AVR (ASX) Chart |